Browsing: Weight Loss

Novo Nordisk said it is asking a U.S. court to preliminarily halt rival Eli Lilly from advertising weight-loss drugs, days after accusing the Indianapolis drugmaker of using deceptive ads to mislead consumers in a lawsuit

Blood sugar support is no longer viewed solely through the lens of diabetes prevention. Instead, it has become a cornerstone of the broader metabolic health conversation. As Denisse Colindres, Senior Manager Nutrition Communication Americas at BENEO, explains: “Driven by the mainstream rise of  GLP-1 medications and a broader consumer awareness of continuous glucose monitoring (CGM),…

Danish pharmaceutical company Novo Nordisk (NVO, Financials), a maker of diabetes and obesity therapies, wants a U.S. court to issue a preliminary injunction to halt rival Eli Lilly’s advertising.Novo accused Lilly of violating false advertising and unfair competition rules with its Zepbound and Mounjaro campaigns for obesity and diabetes treatment respectively.Lilly said Novo compared the…

Roche has discontinued the development of an investigational obesity treatment from its $2.7 billion acquisition of Carmot Therapeutics. Meanwhile, another Carmot candidate is emerging as a potential leader in the weight loss field

The rise has largely occurred since the pandemic and is closely linked to increasing obesity levels, according to an analysis of NHS data from 2011 to 2024

COPENHAGEN, July 24 (Reuters) – Novo Nordisk said on Friday it is seeking a preliminary U.S. court injunction to immediately ‌block obesity and diabetes drug advertisements by Eli Lilly, in ‌a further escalation of the rivalry between the two groups

TGA says product information for some diabetes and weight loss drugs updated with warning of NAION disorder

The study, on the International Milk Genomics Consortium’s (IMGC) website, reports that the large, longitudinal observational study found that whole milk consumption in children 5 years of age is associated with lower adiposity and obesity in middle childhood. 

What’s the leading cause of disability worldwide? If you guessed lower back pain, you’re right

Ismael Bonfim entered fight week 22 pounds over the lightweight limit before his November bout with Chris Padilla, a miscalculation that left him visibly depleted at weigh-ins and ended in a second-round stoppage loss